Can NSTEMI Cause Pericarditis?
Yes, NSTEMI can cause pericarditis, though this is a recognized complication of myocardial infarction rather than a direct causative relationship—the underlying myocardial necrosis from NSTEMI can lead to pericardial inflammation.
Understanding the Relationship
The evidence clearly establishes that pericarditis occurs as a complication following myocardial infarction, including both STEMI and NSTEMI. While the guidelines predominantly discuss pericarditis in the context of STEMI 1, the pathophysiologic mechanism—transmural or near-transmural myocardial necrosis causing pericardial inflammation—can occur with NSTEMI, particularly when there is significant myocardial damage.
Key Clinical Points:
Pericarditis occurs after MI with transmural necrosis 2. While STEMI more commonly causes transmural injury, NSTEMI can produce sufficient myocardial damage to trigger pericardial inflammation, especially in larger infarctions.
The incidence has decreased with modern reperfusion therapy 1, suggesting that limiting infarct size reduces pericarditis risk regardless of whether the MI is STEMI or NSTEMI.
Pericarditis is listed as a trigger for supraventricular arrhythmias in the setting of STEMI 1, indicating it is a recognized post-MI complication.
Clinical Recognition
When evaluating chest pain after NSTEMI, consider pericarditis if the patient presents with:
- Sharp, pleuritic chest pain that is positional (worse when lying flat, better when sitting forward)
- Pain radiating to the trapezius ridge (highly specific for pericarditis)
- Pericardial friction rub on examination
- Recurrent or worsening ST elevation without early T-wave inversion on ECG 1
Critical Differential Diagnosis
The most important clinical imperative is distinguishing pericarditis from reinfarction or acute stent thrombosis 1. This distinction is crucial because management differs dramatically—pericarditis requires anti-inflammatory therapy while recurrent MI requires urgent revascularization.
Management Considerations
If pericarditis develops after NSTEMI:
- Aspirin is first-line treatment (Class I recommendation) 1
- Acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin fails (Class IIb) 1
- Avoid NSAIDs and glucocorticoids (Class III: Harm)—these are potentially harmful after MI 1
Anticoagulation Caution
Exercise caution with anticoagulation in the presence of pericarditis due to risk of hemorrhagic conversion 1. If a pericardial effusion develops:
- Monitor effusion size with echocardiography
- Discontinue anticoagulation if effusion is ≥1 cm or enlarging 1
- Exclude cardiac rupture, especially if effusion width exceeds 1 cm 1
Rare Late Complication: Dressler Syndrome
If pain persists beyond 1 week with systemic features (malaise, fever, elevated inflammatory markers), consider Dressler syndrome—a late autoimmune pericarditis that can occur after any MI, including NSTEMI 1.
Clinical Bottom Line
While pericarditis is more commonly discussed with STEMI due to the transmural nature of that injury, NSTEMI can absolutely cause pericarditis when myocardial necrosis is sufficient to involve the pericardium. The key is recognizing the clinical presentation, distinguishing it from recurrent ischemia, and managing appropriately with aspirin while avoiding NSAIDs and monitoring for hemorrhagic complications if anticoagulation is necessary.